Humalog Solution for Injection (Insulin Lispro) | Used for Type 1 and Type 2 Diabetes Management
Humalog Solution for Injection (Insulin Lispro) is a rapid-acting insulin analog used to control blood sugar levels in adults and children with diabetes mellitus. It works faster than regular human insulin, beginning to act within 15 minutes of injection, reaching peak effect within 30 to 90 minutes, and lasting for 3 to 5 hours. It is typically administered just before or immediately after a meal to manage post-meal blood sugar spikes.
Product Overview
Humalog Solution for Injection is a fast-acting insulin analogue containing Insulin Lispro, designed to provide rapid glycemic control for individuals with diabetes mellitus. This mealtime insulin is engineered to mimic the body’s natural insulin response to food, effectively lowering postprandial blood glucose levels. Whether used for Type 1 or Type 2 diabetes, Humalog offers the flexibility and speed required for a modern diabetes management regimen.
Product Composition
- Insulin Lispro: A laboratory-created rapid-acting insulin where two amino acids in the human insulin molecule are reversed to allow for faster absorption.
- Glycerin: Acts as a stabilizing agent to maintain the isotonicity of the solution.
- Metacresol: Included as a preservative to ensure the sterility and safety of the multi-dose vial or pen.
- Zinc Oxide: Helps in stabilizing the insulin molecules within the injectable solution.
Product Specification
| Feature | Specification Details |
| Therapeutic Category | Antidiabetic / Rapid-Acting Insulin |
| Active Ingredient | Insulin Lispro (rDNA origin) |
| Concentration | 100 Units/mL (U-100) |
| Onset of Action | Approximately 15 minutes |
| Administration | Subcutaneous Injection or Continuous Pump |
Mechanism of Action
- Glucose Uptake Stimulation: Humalog works by binding to insulin receptors on muscle and fat cells, facilitating the entry of glucose into the cells for energy production.
- Hepatic Glucose Regulation: It effectively suppresses glucose production by the liver, preventing blood sugar spikes between meals and during the night.
- Rapid Dissociation: Unlike regular insulin, Insulin Lispro dissociates into monomers almost immediately after injection, leading to accelerated absorption into the bloodstream.
- Lipogenesis Promotion: It encourages the storage of energy by promoting lipid synthesis and inhibiting the breakdown of fats into ketoacids.
Key Benefits
- Mealtime Flexibility: Because of its rapid onset, it can be administered shortly before or even immediately after a meal, fitting easily into a busy lifestyle.
- Reduced Hypoglycemia Risk: Its short duration of action reduces the likelihood of delayed hypoglycemia (low blood sugar) several hours after eating compared to regular human insulin.
- Optimized HbA1c Levels: Helps patients achieve better long-term blood sugar control and reach their target glycosylated hemoglobin (HbA1c) goals.
- Versatile Delivery Options: Compatible with insulin pens, vials, and external insulin pumps for continuous subcutaneous insulin infusion (CSII).
- Improved Post-Meal Control: Specifically targets and limits the sharp rise in sugar levels that occurs after consuming carbohydrates, ensuring glycemic stability.
Usage
Humalog Solution for Injection must be administered via subcutaneous injection in the abdominal wall, thigh, upper arm, or buttocks. Because it is a fast-acting insulin, it should generally be taken within 15 minutes before a meal or immediately after eating. Correct injection technique and site rotation are essential to ensure consistent absorption and prevent skin complications.
Injection Sites: Rotate sites within the chosen area for every injection to reduce the risk of lipodystrophy (skin thickening or pits) or localized inflammation.
Preparation: Always check the insulin appearance before use; the solution must be clear and colorless. Do not use if it is cloudy, thickened, or contains visible particles.
Pump Compatibility: This formulation can be used in an external insulin pump for continuous delivery, but the infusion set and reservoir must be changed according to the manufacturer’s protocol.
Storage Guidelines: Unopened vials or pens should be kept in the refrigerator (2°C to 8°C). Once in use, they can be stored at room temperature for up to 28 days, away from direct heat and light.
Hypoglycemia Awareness: Patients must be trained to recognize and manage low blood sugar symptoms, ensuring a fast-acting carbohydrate source is always available.
Uses
| Indication | Description of Application |
| Type 1 Diabetes | Used as the bolus insulin component in a basal-bolus regimen to manage mealtime glucose. |
| Type 2 Diabetes | Prescribed when oral medications are insufficient to maintain glycemic targets. |
| Gestational Diabetes | Used under specialist care to manage blood sugar during pregnancy when diet alone is not enough. |
| Hyperglycemia Management | Provides rapid correction of high blood glucose levels as part of a personalized sliding scale. |
Targeted Therapeutic Applications
Postprandial Glucose Control: Specifically targets the blood sugar spikes that occur after eating, mimicking the first-phase insulin secretio of a healthy pancreas.
Insulin Pump Therapy: Acts as the sole insulin source in CSII (Continuous Subcutaneous Insulin Infusion), providing both basal and bolus coverage.
Flexible Mealtime Coverage: Ideal for patients with unpredictable schedules, allowing for dose adjustments based on carbohydrate intake at each meal.
Pediatric Diabetes Care: Frequently used in children due to its rapid action, allowing parents to dose based on what the child actually eats during a meal.
Hospitalized Patient Care: Used in clinical settings for the rapid stabilization of blood sugar in patients undergoing surgery or acute illness.
FAQs
Q: What is Humalog Solution for Injection?
A: Humalog is a rapid-acting insulin analog containing Insulin Lispro. It is used to control blood sugar levels in people with type 1 and type 2 diabetes mellitus by mimicking the natural insulin response of the body after a meal.
Q: What is the product used for?
A: Humalog is used to manage high blood sugar levels after meals in adults and children with diabetes mellitus. It is often used alongside a longer-acting insulin to provide complete blood sugar control throughout the day.
Q: How does it work?
A: Insulin Lispro works by allowing glucose from the blood to enter the body's cells where it is used for energy. It acts faster than regular human insulin, helping to control the rise in blood sugar that occurs after eating.
Q: How quickly does it work?
A: Humalog begins to act within 15 minutes of injection, reaches its peak effect within 30 to 90 minutes, and its action lasts for approximately 3 to 5 hours. This makes it ideal for controlling post-meal blood sugar spikes.
Q: How is it administered?
A: It is given by subcutaneous injection (under the skin) into the abdomen, thigh, upper arm, or buttocks. It is available in vials, cartridges, and prefilled pens. It can also be administered via an insulin pump in some cases.
Q: When should it be injected?
A: Humalog should be injected just before a meal or immediately after a meal. The timing should be consistent and follow the doctor's instructions to achieve the best blood sugar control.
Q: What is the correct dose?
A: The dose is individually determined by the doctor based on the patient's blood sugar levels, diet, physical activity, and overall diabetes management plan. Never adjust the dose without consulting your doctor.
Q: Can it be mixed with other insulins?
A: Humalog can be mixed with certain longer-acting insulins such as NPH insulin. However, it should never be mixed with insulin glargine or insulin detemir. Always follow the doctor's instructions regarding mixing.
Q: Who should not use it?
A: Patients with hypoglycemia (low blood sugar) at the time of injection, or those with a known allergy to Insulin Lispro or any of its ingredients should not use Humalog. Always inform your doctor of any allergies before starting treatment.
Q: What are the common side effects?
A: The most common side effect is hypoglycemia (low blood sugar), which can cause shakiness, sweating, dizziness, confusion, and rapid heartbeat. Other side effects include injection site reactions such as redness, swelling, or itching.
Q: What should I do if hypoglycemia occurs?
A: If you experience symptoms of low blood sugar, consume a fast-acting source of glucose such as fruit juice, glucose tablets, or sugar immediately. Inform your doctor if hypoglycemia occurs frequently so the dose can be adjusted.
Q: Is it safe during pregnancy or breastfeeding?
A: Insulin Lispro can be used during pregnancy and breastfeeding but only under strict medical supervision. Blood sugar control is especially important during pregnancy and the dose may need to be adjusted regularly.
Q: Can it be used in children?
A: Yes, Humalog is approved for use in children with diabetes mellitus. The dose is carefully calculated by the doctor based on the child's weight, diet, and blood sugar levels.
Q: How should injection sites be managed?
A: Injection sites should be rotated regularly within the same area to prevent lipodystrophy, which is the thickening or pitting of the skin caused by repeated injections in the same spot.
Q: How should it be stored?
A: Unopened vials and pens should be stored in the refrigerator between 2 and 8 degrees Celsius. Once opened, they can be kept at room temperature below 30 degrees Celsius for up to 28 days.
Interactions
Drug Interactions of Humalog Solution for Injection (Insulin Lispro)
Humalog contains Insulin Lispro. It may interact with certain medicines and affect blood sugar control, leading to hypoglycemia or hyperglycemia.
| Medicine or Substance | Possible Interaction |
|---|---|
| Oral diabetes medicines | May increase risk of low blood sugar |
| Beta blockers | Can mask signs of hypoglycemia like fast heartbeat |
| Alcohol | May increase risk of low blood sugar |
| Corticosteroids | May increase blood sugar levels |
| Diuretics | May reduce blood sugar control |
| Thyroid medicines | May alter insulin requirement |
Important Things to Keep in Mind
- Inform about all medicines before starting insulin
- Monitor blood glucose regularly during combination therapy
- Be alert for signs of low blood sugar
- Do not change other medicines without guidance
- Maintain consistent meal timing for better control
Health Related Interactions
People with kidney disease, liver disease, or irregular eating patterns may experience stronger effects or fluctuations in blood sugar levels. Regular monitoring is important during treatment.
| Manufacturer | : | Eli Lilly And Company |
| Trade Name | : | Humalog |
| Generic Search | : | Insulin Lispro |
| Strength | : | 100IU/ml |
Latest Products
